These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26569500)

  • 1. Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer.
    Yonesaka K; Takegawa N; Satoh T; Ueda H; Yoshida T; Takeda M; Shimizu T; Chiba Y; Okamoto I; Nishio K; Tamura T; Nakagawa K
    PLoS One; 2015; 10(11):e0143132. PubMed ID: 26569500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells.
    Kawakami H; Okamoto I; Yonesaka K; Okamoto K; Shibata K; Shinkai Y; Sakamoto H; Kitano M; Tamura T; Nishio K; Nakagawa K
    Oncotarget; 2014 Dec; 5(23):11847-56. PubMed ID: 25474137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer.
    Kogawa T; Doi A; Shimokawa M; Fouad TM; Osuga T; Tamura F; Mizushima T; Kimura T; Abe S; Ihara H; Kukitsu T; Sumiyoshi T; Yoshizaki N; Hirayama M; Sasaki T; Kawarada Y; Kitashiro S; Okushiba S; Kondo H; Tsuji Y
    Target Oncol; 2015 Mar; 10(1):125-33. PubMed ID: 24859798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of EGFR and EGFR ligand expression on treatment response in patients with metastatic colorectal cancer.
    Klupp F; Sass M; Bergmann F; Khajeh E; Ghamarnejad O; Hassenpflug M; Mehrabi A; Kulu Y
    Oncol Lett; 2021 Jun; 21(6):448. PubMed ID: 33868486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
    Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
    J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant up-regulation of iNOS/NO system is correlated with an increased abundance of Foxp3
    Benkhelifa S; Rafa H; Belhadef S; Ait-Kaci H; Medjeber O; Belkhelfa M; Hetit S; Ait-Younes S; De Launoit Y; Moralès O; Mahfouf H; Delhem N; Touil-Boukoffa C
    Inflammopharmacology; 2019 Aug; 27(4):685-700. PubMed ID: 30680650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer.
    Li Y; Wang B; Yang W; Ma F; Zou J; Li K; Tan S; Feng J; Wang Y; Qin Z; Chen Z; Ding C
    Nat Commun; 2024 Feb; 15(1):980. PubMed ID: 38302471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiregulin as a Novel Serum Marker of Puberty in Girls.
    Biro FM; Pinney SM; Schwartz RC; Huang B; Cattran AM; Haslam SZ
    J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):535-539. PubMed ID: 28216130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies.
    Li Y; Wang B; Ma F; Jiang D; Wang Y; Li K; Tan S; Feng J; Wang Y; Qin Z; Xu G; Tian S; Zhang X; Xu C; Wu J; Xu J; Hou Y; Ding C
    Cell Rep Med; 2023 Dec; 4(12):101311. PubMed ID: 38086380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D stochastic microsensors for molecular recognition and determination of heregulin-α in biological samples.
    Stefan-van Staden RI; Negut CC; Gheorghe SS; Ciorîță A
    Anal Bioanal Chem; 2021 May; 413(13):3487-3492. PubMed ID: 33763747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controls.
    Peterson EA; Pectasides E; Shabbeer S; Wiechmann L; Sparano JA; Kenny PA
    Exp Hematol Oncol; 2013 Sep; 2(1):25. PubMed ID: 24010672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to EGFR-targeted therapy: a family affair.
    Vlacich G; Coffey RJ
    Cancer Cell; 2011 Oct; 20(4):423-5. PubMed ID: 22014569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy: another tool towards tailored therapy in colorectal cancer.
    Tarazona N; Cervantes A
    Ann Oncol; 2018 Jan; 29(1):7-8. PubMed ID: 29045545
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.
    Buta C; Benabou E; Lequoy M; Régnault H; Wendum D; Merabtene F; Chettouh H; Aoudjehane L; Conti F; Chrétien Y; Scatton O; Rosmorduc O; Praz F; Fartoux L; Desbois-Mouthon C
    J Exp Clin Cancer Res; 2016 Sep; 35(1):154. PubMed ID: 27680564
    [No Abstract]   [Full Text] [Related]  

  • 15. GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands.
    Lim Y; Yoo J; Kim MS; Hur M; Lee EH; Hur HS; Lee JC; Lee SN; Park TW; Lee K; Chang KH; Kim K; Kang Y; Hong KW; Kim SH; Kim YG; Yoon Y; Nam DH; Yang H; Kim DG; Cho HS; Won J
    Mol Cancer Ther; 2016 Feb; 15(2):251-63. PubMed ID: 26586721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.
    Liao HW; Hsu JM; Xia W; Wang HL; Wang YN; Chang WC; Arold ST; Chou CK; Tsou PH; Yamaguchi H; Fang YF; Lee HJ; Lee HH; Tai SK; Yang MH; Morelli MP; Sen M; Ladbury JE; Chen CH; Grandis JR; Kopetz S; Hung MC
    J Clin Invest; 2015 Dec; 125(12):4529-43. PubMed ID: 26571401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old dog, new tricks: extracellular domain arginine methylation regulates EGFR function.
    Epstein DM; Buck E
    J Clin Invest; 2015 Dec; 125(12):4320-2. PubMed ID: 26571394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic evaluation of panitumumab in the treatment of colorectal cancer.
    Lo L; Patel D; Townsend AR; Price TJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1907-24. PubMed ID: 26572750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma.
    Cheng L; Xia Z; Bian X; Li G; Hu J; Cao Y; Wang Q; Qian X
    Onco Targets Ther; 2015; 8():3185-92. PubMed ID: 26586952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
    Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
    Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.